These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2249982)

  • 1. Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations.
    Neville LF; Gnatt A; Padan R; Seidman S; Soreq H
    J Biol Chem; 1990 Dec; 265(34):20735-8. PubMed ID: 2249982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramolecular relationships in cholinesterases revealed by oocyte expression of site-directed and natural variants of human BCHE.
    Neville LF; Gnatt A; Loewenstein Y; Seidman S; Ehrlich G; Soreq H
    EMBO J; 1992 Apr; 11(4):1641-9. PubMed ID: 1373381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspartate-70 to glycine substitution confers resistance to naturally occurring and synthetic anionic-site ligands on in-ovo produced human butyrylcholinesterase.
    Neville LF; Gnatt A; Loewenstein Y; Soreq H
    J Neurosci Res; 1990 Dec; 27(4):452-60. PubMed ID: 2079709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-directed mutagenesis of active site residues reveals plasticity of human butyrylcholinesterase in substrate and inhibitor interactions.
    Gnatt A; Loewenstein Y; Yaron A; Schwarz M; Soreq H
    J Neurochem; 1994 Feb; 62(2):749-55. PubMed ID: 8294937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.
    Loewenstein Y; Gnatt A; Neville LF; Soreq H
    J Mol Biol; 1993 Nov; 234(2):289-96. PubMed ID: 8230213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pesticide poisoning, succinylcholine-induced apnea, and pseudocholinesterase.
    Nelson TC; Burritt MF
    Mayo Clin Proc; 1986 Sep; 61(9):750-2. PubMed ID: 3747617
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), "silent" with mivacurium.
    Delacour H; Lushchekina S; Mabboux I; Ceppa F; Masson P; Schopfer LM; Lockridge O
    Biochem Pharmacol; 2014 Dec; 92(3):476-83. PubMed ID: 25264279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlapping drug interaction sites of human butyrylcholinesterase dissected by site-directed mutagenesis.
    Loewenstein-Lichtenstein Y; Glick D; Gluzman N; Sternfeld M; Zakut H; Soreq H
    Mol Pharmacol; 1996 Dec; 50(6):1423-31. PubMed ID: 8967962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asp7O in the peripheral anionic site of human butyrylcholinesterase.
    Masson P; Froment MT; Bartels CF; Lockridge O
    Eur J Biochem; 1996 Jan; 235(1-2):36-48. PubMed ID: 8631355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of human plasma cholinesterase variants in 6,688 individuals using biochemical analysis.
    Jensen FS; Skovgaard LT; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1995 Feb; 39(2):157-62. PubMed ID: 7793180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sheep brain pseudocholinesterase: inhibition kinetics of the partially purified enzyme by some substrate analogues.
    Cokuğraş AN; Tezcan EF
    Chem Biol Interact; 1993 Jun; 87(1-3):259-64. PubMed ID: 8343984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance of butyrylcholinesterase phenotype with genotype: implications for biochemical reporting.
    Parnas ML; Procter M; Schwarz MA; Mao R; Grenache DG
    Am J Clin Pathol; 2011 Feb; 135(2):271-6. PubMed ID: 21228368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of butyrylcholinesterase gene mutations in individuals with abnormal inhibition numbers: an Italian-population study.
    Lando G; Mosca A; Bonora R; Azzario F; Penco S; Marocchi A; Panteghini M; Patrosso MC
    Pharmacogenetics; 2003 May; 13(5):265-70. PubMed ID: 12724618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged response to succinylcholine: a new variant of plasma cholinesterase that is identified as normal by traditional phenotyping methods.
    Greenberg CP; Primo-Parmo SL; Pantuck EJ; la Du BN
    Anesth Analg; 1995 Aug; 81(2):419-21. PubMed ID: 7618741
    [No Abstract]   [Full Text] [Related]  

  • 15. Dibucaine inhibition of serum cholinesterase.
    Elamin B
    J Biochem Mol Biol; 2003 Mar; 36(2):149-53. PubMed ID: 12689511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of aspartate 70 and tryptophan 82 in binding of succinyldithiocholine to human butyrylcholinesterase.
    Masson P; Legrand P; Bartels CF; Froment MT; Schopfer LM; Lockridge O
    Biochemistry; 1997 Feb; 36(8):2266-77. PubMed ID: 9047329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase.
    Masson P; Froment MT; Bartels CF; Lockridge O
    Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):53-61. PubMed ID: 9224629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholinesterases].
    Lejus C; Blanloeil Y; Burnat P; Souron R
    Ann Fr Anesth Reanim; 1998; 17(9):1122-35. PubMed ID: 9835982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pseudocholinesterase variants. Esterase levels and dibucaine numbers in families selected through suxamethonium sensitive individuals.
    HARRIS H; WHITTAKER M; LEHMANN H; SILK E
    Acta Genet Stat Med; 1960; 10():1-16. PubMed ID: 14399955
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of alternatively terminated unusual human butyrylcholinesterase messenger RNA transcripts, mapping to chromosome 3q26-ter, in nervous system tumors.
    Gnatt A; Prody CA; Zamir R; Lieman-Hurwitz J; Zakut H; Soreq H
    Cancer Res; 1990 Apr; 50(7):1983-7. PubMed ID: 2317787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.